Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia

Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach

DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649 · see citing works

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101 · see citing works

Circulating angiogenic factors and the risk of preeclampsia

Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720 · see citing works

Circulating angiogenic factors and the risk of preeclampsia*

(2004) · Obstetrics and Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,623 · see citing works

Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia

Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R. J., Thadhani, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055352 · Cited by 1,804 · see citing works

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,393 · see citing works

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

Eremina, V., Sood, M. M., Haigh, J. J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H. P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,308 · see citing works

Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia

(2006) · New England Journal of Medicine · doi:10.1056/nejmx060063 · Cited by 1,237 · see citing works

Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia

ACOG Committee on Obstetric Practice (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01747-1 · Cited by 1,059 · see citing works

Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987-2004

Wallis, A. B., Saftlas, A. F., Hsia, J., & Atrash, H. K. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.20 · Cited by 766 · see citing works

Preterm premature rupture of the membranes

Mercer, B. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02366-9 · Cited by 742 · see citing works

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

Romero, R. J., Nien, J. K., Espinoza, J., Todem, D., Fu, W., Chung, H., Kusanovic, J. P., Gotsch, F., Erez, O., Mazaki‐Tovi, S., et al. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050701830480 · Cited by 675 · see citing works

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

von Dadelszen, P., Payne, B. A., Li, J., Ansermino, J. M., Pipkin, F. B., Côté, A., Douglas, M. J., Gruslin, A., Hutcheon, J. A., Joseph, K. S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61351-7 · Cited by 585 · see citing works

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial

Sibai, B. M., Mercer, B. M., Schiff, E., & Friedman, S. A. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90104-x · Cited by 458 · see citing works

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia

Verlohren, S., Galindo, A., Schlembach, D., Zeisler, H., Herraı̀z, I., Moertl, M. G., Pape, J., Dudenhausen, J. W., Denk, B., & Stepan, H. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.09.016 · Cited by 429 · see citing works

Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension

Roberts, J. M., Myatt, L., Spong, C. Y., Thom, E. A., Hauth, J. C., Leveno, K. J., Pearson, G. D., Wapner, R. J., Varner, M. W., Thorp, J. M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908056 · Cited by 402 · see citing works

Hypertension in Pregnancy

Fisher, K. A., Luger, A., Spargo, B. H., & Lindheimer, M. D. (1981) · Medicine · doi:10.1097/00005792-198107000-00002 · Cited by 374 · see citing works

Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension

Noori, M., Donald, A. E., Angelakopoulou, A., Hingorani, A. D., & Williams, D. J. (2010) · Circulation · doi:10.1161/circulationaha.109.895458 · Cited by 361 · see citing works

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

Chaiworapongsa, T., Romero, R., Kim, Y. M., Kim, G. J., Kim, M. R., Espinoza, J., Bujold, E., Gonçalves, L., Gomez, R., Edwin, S., et al. (2005) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050400028816 · Cited by 359 · see citing works

Diagnosis and management of atypical preeclampsia-eclampsia

Sibai, B. M., & Stella, C. L. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.07.048 · Cited by 353 · see citing works

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Thadhani, R., Kisner, T., Hagmann, H., Boßung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O. A., Kreyssig, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.034793 · Cited by 347 · see citing works

Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial.

Odendaal, H. J., Pattinson, R., Bam, R. H., Grove, D., & Tj, K. (1990) · PubMed · Cited by 285 · see citing works

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

Kusanovic, J. P., Romero, R. J., Chaiworapongsa, T., Erez, O., Mittal, P., Vaisbuch, E., Mazaki‐Tovi, S., Gotsch, F., Edwin, S. S., Gómez, R., et al. (2009) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050902994754 · Cited by 277 · see citing works

Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia

Li, Z., Zhang, Y., Jing, Y., Kapoun, A. M., Shao, Q., Kerr, I., Lam, A., O’Young, G., Sannajust, F. J., Stathis, P., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.092098 · Cited by 258 · see citing works

The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice

Lu, F., Longo, M., Tamayo, E. H., Maner, W. L., Al-Hendy, A. A., Anderson, G. D., Hankins, G. D. V., & Saade, G. R. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.12.024 · Cited by 224 · see citing works

VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma

Maharaj, A. S. R., Walshe, T. E., Saint‐Geniez, M., Venkatesha, S., Maldonado, A. E., Himes, N. C., Matharu, K., Karumanchi, S. A., & D'Amore, P. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072041 · Cited by 186 · see citing works

Neonatal outcome after preterm delivery for preeclampsia

Friedman, S. A., Schiff, E., Kao, L., & Sibai, B. M. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91412-9 · Cited by 182 · see citing works

Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study

Sunderji, S., Gaziano, E. P., Wothe, D. D., Rogers, L. C., Sibai, B. M., Karumanchi, S. A., & Hodges-Savola, C. A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.07.025 · Cited by 132 · see citing works

Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?

Stamilio, D. M., Sehdev, H. M., Morgan, M. A., PROPERT, K. J., & Macones, G. A. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.103890 · Cited by 128 · see citing works

New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications

Ahmed, A. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70020-2 · Cited by 127 · see citing works

Current CHS and NHBPEP Criteria for Severe Preeclampsia Do Not Uniformly Predict Adverse Maternal or Perinatal Outcomes

Menzies, J., Magee, L. A., MacNab, Y. C., Ansermino, J. M., Li, J., Douglas, M. J., Gruslin, A., Kyle, P. M., Lee, S. K., Moore, M. P., et al. (2007) · Hypertension in Pregnancy · doi:10.1080/10641950701521742 · Cited by 114 · see citing works

Preterm Premature Rupture of the Membranes

Mercer, B. M. (2003) · Obstetrics and Gynecology · doi:10.1097/00006250-200301000-00033 · Cited by 109 · see citing works

Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy

Ganzevoort, W., Rep, A., de Vries, J. I. P., Bonsel, G. J., & Wolf, H. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.02.012 · Cited by 107 · see citing works

Preterm Premature Rupture of the Membranes

Mercer, B. M. (2008) · The Global Library of Women s Medicine · doi:10.3843/glowm.10120 · Cited by 72 · see citing works

The Role of Serum Uric Acid as a Prognostic Indicator of the Severity of Maternal and Fetal Complications in Hypertensive Pregnancies

Williams, K. P., & Galerneau, F. (2002) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30193-1 · Cited by 63 · see citing works

Prediction of Adverse Maternal Outcomes in Preeclampsia

von Dadelszen, P., Payne, B. A., Li, J., Ansermino, J. M., Pipkin, F. B., Côté, A., Douglas, M. J., Gruslin, A., Hutcheon, J. A., Joseph, K. S., et al. (2012) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000410808.61878.a4 · Cited by 36 · see citing works

Prognostic Role of Uterine Artery Doppler in Patients with Preeclampsia

Meler, E., Figueras, F., Mula, R., Crispi, F., Benassar, M., Gómez, O., & Gratacós, E. (2009) · Fetal Diagnosis and Therapy · doi:10.1159/000258048 · Cited by 34 · see citing works

Technical performance of the first fully automated assays for human soluble fms-like tyrosine kinase 1 and human placental growth factor

Schneider, E., Gleixner, A., Hänel, R., Leyhe, Y., Kleinschmidt, C. K., Beck, G., Steinberg, M., Denk, B., & Gassner, D. (2009) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/s-0029-1216308 · Cited by 15 · see citing works

Untitled work

Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095 · see citing works

Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice

Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10803 · Cited by 2,089 · see citing works

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia

Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,820 · see citing works

Pre-eclampsia

Mol, B. W., Roberts, C. T., Thangaratinam, S., Magee, L. A., de Groot, C. J. M., & Hofmeyr, G. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00070-7 · Cited by 1,619 · see citing works

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP

Tranquilli, A. L., Dekker, G., Magee, L. A., Roberts, J. M., Sibai, B. M., Steyn, W., Zeeman, G. G., & Brown, M. A. (2014) · Pregnancy Hypertension · doi:10.1016/j.preghy.2014.02.001 · Cited by 1,419 · see citing works

Pre-eclampsia: pathogenesis, novel diagnostics and therapies

Phipps, E. A., Thadhani, R., Benzing, T. R., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,255 · see citing works

The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice

Magee, L. A., Brown, M. A., Hall, D. R., Gupte, S., Hennessy, A., Karumanchi, S. A., Kenny, L. C., McCarthy, F., Myers, J., Poon, L. C., et al. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.09.008 · Cited by 1,134 · see citing works

The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice

Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C., Adoyi, G., & Ishaku, S. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.05.004 · Cited by 1,089 · see citing works

Pre-eclampsia

Chappell, L. C., Cluver, C. A., Kingdom, J. C., & Tong, S. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32335-7 · Cited by 977 · see citing works

Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia

Chappell, L. C., Duckworth, S., Seed, P. T., Griffin, M., Myers, J., Mackillop, L. H., Simpson, N., Waugh, J. J. S., Anumba, D. O. C., Kenny, L. C., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003215 · Cited by 501 · see citing works

Tracking placental development in health and disease

Aplin, J., Myers, J., Timms, K., & Westwood, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0372-6 · Cited by 381 · see citing works

New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia

Verlohren, S., Herraı̀z, I., Lapaire, O., Schlembach, D., Zeisler, H., Calda, P., Sabrià, J., Markfeld-Erol, F., Galindo, A., Schoofs, K., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01787 · Cited by 375 · see citing works

Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders

Rana, S., Burke, S. D., & Karumanchi, S. A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.022 · Cited by 351 · see citing works

<scp>SOMANZ</scp>guidelines for the management of hypertensive disorders of pregnancy 2014

Lowe, S. A., Bowyer, L., Lust, K., McMahon, L. P., Morton, M., North, R. A., Paech, M., & Said, J. M. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12399 · Cited by 299 · see citing works

Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia

Thadhani, R., Hagmann, H., Schaarschmidt, W., Roth, B., Cingoez, T., Karumanchi, S. A., Wenger, J., Lucchesi, K. J., Tamez, H. E., Lindner, T. H., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015020157 · Cited by 278 · see citing works

Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors

Tomimatsu, T., Mimura, K., Matsuzaki, S., Endo, M., Kumasawa, K., & Kimura, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174246 · Cited by 282 · see citing works

Early Prediction of Preeclampsia

Poon, L. C., & Nicolaides, K. H. (2014) · Obstetrics and Gynecology International · doi:10.1155/2014/297397 · Cited by 273 · see citing works

Implementation of the sFlt ‐1/ PlGF ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practice

Stepan, H., Herraı̀z, I., Schlembach, D., Verlohren, S., Brennecke, S. P., Chantraine, F., Klein, E. E., Lapaire, O., Llurba, E., Ramoni, A., et al. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14799 · Cited by 266 · see citing works

Pathogenesis of preeclampsia

Sircar, M., Thadhani, R., & Karumanchi, S. A. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000105 · Cited by 256 · see citing works

Pathophysiology and epidemiology of peripartum cardiomyopathy

Hilfiker‐Kleiner, D., & Sliwa, K. S. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.37 · Cited by 253 · see citing works

Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity

Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253 · see citing works

Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications

Jim, B., & Karumanchi, S. A. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2017.05.011 · Cited by 250 · see citing works

Clinical utility of <scp>sFlt</scp> ‐1 and <scp>PlGF</scp> in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction

Stepan, H., Galindo, A., Hund, M., Schlembach, D., Sillman, J., Surbek, D., & Vatish, M. (2023) · Ultrasound in Obstetrics &amp; Gynecology · doi:10.1002/uog.26032 · Cited by 245 · see citing works

Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia

Stepan, H., Hund, M., & Andraczek, T. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13763 · Cited by 241 · see citing works

Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia

Verlohren, S., Brennecke, S. P., Galindo, A., Karumanchi, S. A., Mirković, L., Schlembach, D., Stepan, H., Vatish, M., Zeisler, H., & Rana, S. (2021) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.12.003 · Cited by 242 · see citing works

RNAi modulation of placental sFLT1 for the treatment of preeclampsia

Turanov, A. A., Lo, A. S., Hassler, M. R., Makris, A., Ashar-Patel, A., Alterman, J. F., Coles, A. H., Haraszti, R. Á., Roux, L., Godinho, B. M. D. C., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4297 · Cited by 212 · see citing works

Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period

Goel, A., Maski, M. R., Bajracharya, S., Wenger, J., Zhang, D., Salahuddin, S., Shahul, S. S., Thadhani, R., Seely, E. W., Karumanchi, S. A., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015721 · Cited by 205 · see citing works

Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches

Armaly, Z., Jadaon, J. E., Jabbour, A. R., & Abassi, Z. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00973 · Cited by 208 · see citing works

Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia

Agrawal, S., Cerdeira, A. S., Redman, C. W. G., & Vatish, M. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10182 · Cited by 180 · see citing works

Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine

Dröge, L. A., Perschel, F. H., Stütz, N., Gafron, A., Frank, L., Busjahn, A., Henrich, W., & Verlohren, S. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15146 · Cited by 169 · see citing works

A placenta clinic approach to the diagnosis and management of fetal growth restriction

Kingdom, J. C., Audette, M. C., Hobson, S. R., Windrim, R. C., & Morgen, E. K. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.575 · Cited by 167 · see citing works

Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy

Karumanchi, S. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06421 · Cited by 163 · see citing works

Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia

Cerdeira, A. S., O’Sullivan, J. M., Ohuma, E. O., Harrington, D. J., Szafranski, P., Black, R., Mackillop, L. H., Impey, L. W. M., Greenwood, C. E. L., James, T. J., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12739 · Cited by 162 · see citing works

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile

Rana, S., Schnettler, W. T., Powe, C. E., Wenger, J., Salahuddin, S., Cerdeira, A. S., Verlohren, S., Perschel, F. H., Arany, Z. P., Lim, K.-H., et al. (2013) · Hypertension in Pregnancy · doi:10.3109/10641955.2013.784788 · Cited by 155 · see citing works

Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction

Tomimatsu, T., Mimura, K., Endo, M., Kumasawa, K., & Kimura, T. (2016) · Hypertension Research · doi:10.1038/hr.2016.152 · Cited by 154 · see citing works

Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history

Tsiakkas, A., Duvdevani, N., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14811 · Cited by 152 · see citing works

Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension

Khosla, K., Heimberger, S., Nieman, K. M., Tung, A., Shahul, S. S., Staff, A. C., & Rana, S. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.16506 · Cited by 151 · see citing works

First‐trimester maternal factors and biomarker screening for preeclampsia

Poon, L. C., & Nicolaides, K. H. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4397 · Cited by 150 · see citing works

A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy

Cabiddu, G., Castellino, S., Gernone, G., Santoro, D., Moroni, G. L., Giannattasio, M., Gregorini, G. A., Giacchino, F., Attini, R., Loi, V., et al. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0285-6 · Cited by 152 · see citing works

Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension

Spradley, F. T., Tan, A. Y., Joo, W. S., Daniels, G., Kussie, P. H., Karumanchi, S. A., & Granger, J. P. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06783 · Cited by 145 · see citing works

Advances in the pathophysiology of pre-eclampsia and related podocyte injury

Craici, I. M., Wagner, S. J., Weissgerber, T. L., Grande, J. P., & Garovic, V. D. (2014) · Kidney International · doi:10.1038/ki.2014.17 · Cited by 146 · see citing works

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia

Chaiworapongsa, T., Romero, R. J., Korzeniewski, S. J., Kusanovic, J. P., Soto, E., Lam, J., Dong, Z., Than, N. G., Yeo, L., Hernandez‐Andrade, E. A., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.016 · Cited by 144 · see citing works

Maternal cardiac metabolism in pregnancy

Liu, L. X., & Arany, Z. P. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu009 · Cited by 144 · see citing works

Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting

Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M. H., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19178 · Cited by 144 · see citing works

Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy

Thadhani, R., Lemoine, E. R., Rana, S., Costantine, M. M., Calsavara, V. F., Boggess, K., Wylie, B. J., Simas, T. A. M., Louis, J. M., Espinoza, J., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2200161 · Cited by 149 · see citing works

Neutrophil NETs in reproduction: from infertility to preeclampsia and the possibility of fetal loss

Hahn, S., Giaglis, S., Hoesli, I. M., & Hasler, P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00362 · Cited by 142 · see citing works

Association Between Hypertensive Disorders of Pregnancy and Later Risk of Cardiomyopathy

Behrens, I., Basit, S., Lykke, J. A., Ranthe, M. F., Wohlfahrt, J., Bundgaard, H., Melbye, M., & Boyd, H. A. (2016) · JAMA · doi:10.1001/jama.2016.1869 · Cited by 144 · see citing works

Diagnosis of acute neurological emergencies in pregnant and post-partum women

Edlow, J. A., Caplan, L. R., O’Brien, K., & Tibbles, C. D. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70306-x · Cited by 141 · see citing works

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia

Bian, X.-M., Biswas, A., Huang, X., Lee, K. J., Li, T. K. T., Masuyama, H., Ohkuchi, A., Park, J. S., Saito, S., Tan, K. H., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12760 · Cited by 141 · see citing works

Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/ PlGF Ratio in Singleton Pregnancies

Herraı̀z, I., Llurba, E., Verlohren, S., Galindo, A., & on behalf of the Spanish Group for the Study of Angiogenic Markers in Preeclampsia (2017) · Fetal Diagnosis and Therapy · doi:10.1159/000477903 · Cited by 140 · see citing works

The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia

Hagmann, H., Thadhani, R., Benzing, T. R., Karumanchi, S. A., & Stepan, H. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.169094 · Cited by 136 · see citing works

Pre-eclampsia part 2: prediction, prevention and management

Chaiworapongsa, T., Chaemsaithong, P., Korzeniewski, S. J., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.103 · Cited by 132 · see citing works

Maternal Vascular Malperfusion and Adverse Perinatal Outcomes in Low-Risk Nulliparous Women

Wright, E., Audette, M. C., Ye, X. Y., Keating, S. J., Hoffman, B., Lye, S. J., Shah, P. S., & Kingdom, J. C. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002264 · Cited by 133 · see citing works

Thrombotic microangiopathies of pregnancy: Differential diagnosis

Gupta, M., Feinberg, B. B., & Burwick, R. M. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.02.007 · Cited by 135 · see citing works

Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia

Rana, S., Karumanchi, S. A., & Lindheimer, M. D. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02293 · Cited by 131 · see citing works

The renin–angiotensin–aldosterone system in pre-eclampsia: the delicate balance between good and bad

Verdonk, K., Visser, W. E., van den Meiracker, A. H., & Danser, A. H. J. (2013) · Clinical Science · doi:10.1042/cs20130455 · Cited by 130 · see citing works

EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

Williamson, C., Nana, M., Poon, L. C., Kupčinskas, L., Painter, R. C., Taliani, G., Heneghan, M. A., Marschall, H., & Beuers, U. H. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.006 · Cited by 137 · see citing works

G-Protein-Coupled Receptor Kinase 2 and Hypertension

Santulli, G., Trimarco, B., & Iaccarino, G. (2013) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-013-0001-8 · Cited by 123 · see citing works

Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review

Ukah, U. V., Silva, D. A. D., Payne, B. A., Magee, L. A., Hutcheon, J. A., Brown, H. L., Ansermino, J. M., Lee, T., & von Dadelszen, P. (2017) · Pregnancy Hypertension · doi:10.1016/j.preghy.2017.11.006 · Cited by 122 · see citing works

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks’ gestation

Tsiakkas, A., Saiid, Y., Wright, A., Wright, D., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.02.016 · Cited by 119 · see citing works

Recent Advances in the Understanding of the Pathophysiology of Preeclampsia

Warrington, J. P., George, E. M., Palei, A. C., Spradley, F. T., & Granger, J. P. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00588 · Cited by 120 · see citing works

Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial

Rayman, M. P., Searle, E., Kelly, L. A., Johnsen, S., Bodman-Smith, K. B., Bath, S. C., Mao, J., & Redman, C. W. G. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000531 · Cited by 117 · see citing works

Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation

Andrietti, S., Silva, M. D. L., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15812 · Cited by 116 · see citing works

Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration

Herraı̀z, I., Simon, E. D. S., Gómez‐Arriaga, P. I., Martínez-Moratalla, J. M., García-Burguillo, A., Jiménez, E., & Galindo, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160819009 · Cited by 114 · see citing works

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Devuyst, O., Ahn, C., Barten, T. R. M., Brosnahan, G., Cadnapaphornchai, M. A., Chapman, A. B., Gall, É. C.-L., Drenth, J. P. H., Gansevoort, R. T., Harris, P. C., et al. (2025) · Kidney International · doi:10.1016/j.kint.2024.07.009 · Cited by 142 · see citing works

Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study

Korzeniewski, S. J., Romero, R. J., Chaiworapongsa, T., Chaemsaithong, P., Kim, C. J., Kim, Y. M., Kim, J.-S., Yoon, B. H., Hassan, S. S., & Yeo, L. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.015 · Cited by 112 · see citing works

Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia

Verlohren, S., Melchiorre, K., Khalil, A. A., & Thilaganathan, B. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.13310 · Cited by 110 · see citing works

Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies

Boyd, H. A., Basit, S., Behrens, I., Leirgul, E., Bundgaard, H., Wohlfahrt, J., Melbye, M., & Øyen, N. (2017) · Circulation · doi:10.1161/circulationaha.116.024600 · Cited by 109 · see citing works

Noncanonical mitochondrial unfolded protein response impairs placental oxidative phosphorylation in early-onset preeclampsia

Yung, H. W., Colleoni, F., Dommett, E., Cindrová‐Davies, T., Kingdom, J. C., Murray, A. J., & Burton, G. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907548116 · Cited by 110 · see citing works

Placental growth factor (PlGF): a key to optimizing fetal growth

Vrachnis, N., Kalampokas, E., Sifakis, S., Vitoratos, N., Kalampokas, T., Botsis, D., & Iliodromiti, Z. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.766694 · Cited by 105 · see citing works

Competing endogenous RNA expression profiling in pre-eclampsia identifies hsa_circ_0036877 as a potential novel blood biomarker for early pre-eclampsia

Hu, X., Ao, J., Li, X., Zhang, H., Wu, J., & Cheng, W. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0482-3 · Cited by 103 · see citing works

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia

Poon, L. C., Magee, L. A., Verlohren, S., Shennan, A. H., von Dadelszen, P., Sheiner, E., Hadar, E., Visser, G. H. A., Costa, F. D. S., Kapur, A., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13763 · Cited by 118 · see citing works

Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies With Suspected Preeclampsia

Rana, S., Hacker, M. R., Modest, A. M., Salahuddin, S., Lim, K.-H., Verlohren, S., Perschel, F. H., & Karumanchi, S. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195065 · Cited by 103 · see citing works

Recent advances in the diagnosis and management of pre-eclampsia

Duhig, K. E., & Shennan, A. H. (2015) · F1000Prime Reports · doi:10.12703/p7-24 · Cited by 101 · see citing works

Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction

Herraı̀z, I., Dröge, L. A., Gómez‐Montes, E., Henrich, W., Galindo, A., & Verlohren, S. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000367 · Cited by 98 · see citing works

New Developments in the Pathogenesis of Preeclampsia

Naljayan, M. V., & Karumanchi, S. A. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.02.003 · Cited by 94 · see citing works

Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia

Lim, S., Li, W., Kemper, J., Nguyen, A., Mol, B. W., & Reddy, M. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004149 · Cited by 99 · see citing works

Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes

Leaños‐Miranda, A., Navarro-Romero, C. S., Sillas-Pardo, L. J., Ramírez-Valenzuela, K. L., Isordia‐Salas, I., & Jiménez-Trejo, L. M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13348 · Cited by 89 · see citing works

Complement in Pregnancy: A Delicate Balance

Denny, K. J., Woodruff, T. M., Taylor, S. M., & Callaway, L. K. (2012) · American Journal of Reproductive Immunology · doi:10.1111/aji.12000 · Cited by 90 · see citing works

Angiogenic balance (sFlt-1/PlGF) and preeclampsia

Lecarpentier, É., & Tsatsaris, V. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.04.007 · Cited by 89 · see citing works

Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study

Chaiworapongsa, T., Romero, R. J., Korzeniewski, S. J., Cortez, J. M., Pappas, A., Tarca, A. L., Chaemsaithong, P., Dong, Z., Yeo, L., & Hassan, S. S. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.806905 · Cited by 88 · see citing works

Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia

Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M. H., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001525 · Cited by 86 · see citing works

Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis

Gray, K. J., Saxena, R., & Karumanchi, S. A. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.562 · Cited by 87 · see citing works

Sequential plasma angiogenic factors levels in women with suspected preeclampsia

Baltajian, K., Bajracharya, S., Salahuddin, S., Berg, A. H., Geahchan, C., Wenger, J. B., Thadhani, R., Karumanchi, S. A., & Rana, S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.01.168 · Cited by 88 · see citing works

The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia*

Chaiworapongsa, T., Romero, R. J., Whitten, A. E., Korzeniewski, S. J., Chaemsaithong, P., Hernandez‐Andrade, E. A., Yeo, L., & Hassan, S. S. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1048431 · Cited by 80 · see citing works

Preeclampsia and Kidney Disease: Deciphering Cause and Effect

Kattah, A. G. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01099-1 · Cited by 86 · see citing works

A machine-learning–based algorithm improves prediction of preeclampsia-associated adverse outcomes

Schmidt, L. J., Rieger, O., Neznansky, M., Hackelöer, M., Dröge, L. A., Henrich, W., Higgins, D., & Verlohren, S. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.01.026 · Cited by 81 · see citing works

Gestational Hypertension and Preeclampsia: Are They the Same Disease?

Melamed, N., Ray, J. G., Hladunewich, M., Cox, B., & Kingdom, J. C. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30545-4 · Cited by 81 · see citing works

The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia

Verlohren, S., & Dröge, L.-A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.09.046 · Cited by 83 · see citing works

Placental Disease and the Maternal Syndrome of Preeclampsia: Missing Links?

Tannetta, D., & Sargent, I. L. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0395-7 · Cited by 80 · see citing works

Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction

Sibiude, J., Guibourdenche, J., Dionne, M.-D., Ray, C. L., Anselem, O., Serreau, R., Goffinet, F., & Tsatsaris, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050208 · Cited by 79 · see citing works

Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia

Saffer, C. S., Olson, G., Boggess, K., Beyerlein, R., Eubank, C., & Sibai, B. M. (2013) · Pregnancy Hypertension · doi:10.1016/j.preghy.2013.01.004 · Cited by 79 · see citing works

Maternal serum sFlt ‐1/ PlGF ratio in twin pregnancies with and without pre‐eclampsia in comparison with singleton pregnancies

Dröge, L.-A., Herraı̀z, I., Zeisler, H., Schlembach, D., Stepan, H., Küssel, L., Henrich, W., Galindo, A., & Verlohren, S. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14760 · Cited by 79 · see citing works

sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)

Alfredo Perales, M., Delgado⋈, J. L., de la Calle, M., García‐Hernández, J. A., Escudero, A. I., Maza, J. M. C., Sarabia, M. D., Laíz, B., Duque, M., Navarro, M., et al. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17373 · Cited by 81 · see citing works

Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center

Caillon, H., Tardif, C., Dumontet, E., Winer, N., & Masson, D. (2017) · Annals of Laboratory Medicine · doi:10.3343/alm.2018.38.2.95 · Cited by 78 · see citing works

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia

Klein, E., Schlembach, D., Ramoni, A., Langer, E., Bahlmann, F., Grill, S., Schaffenrath, H., van der Does, R., Messinger, D., Verhagen-Kamerbeek, W. D. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156013 · Cited by 77 · see citing works

Angiogenic and antiangiogenic factors in preeclampsia

Helmo, F. R., Lopes, A. M. M., Carneiro, A. C. D. M., Campos, C. G., Silva, P. B., Monteiro, M. L. G. D. R., Rocha, L. P., dos Reis, M. A., Etchebehere, R. M., Machado, J. R., et al. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.10.021 · Cited by 78 · see citing works

Angiogenic biomarkers in triage and risk for preeclampsia with severe features

Rana, S., Salahuddin, S., Mueller, A., Berg, A. H., Thadhani, R., & Karumanchi, S. A. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.05.008 · Cited by 77 · see citing works

Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort

Villa, P., Hämäläinen, E. K., Mäki, A., Räikkönen, K., Pesonen, A., Taipale, P., Kajantie, E., & Laivuori, H. M. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-110 · Cited by 76 · see citing works

Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol

Hund, M., Allegranza, D., Schoedl, M., Dilba, P., Verhagen-Kamerbeek, W. D. J., & Stepan, H. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-324 · Cited by 77 · see citing works

Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies With Suspected Preeclampsia

Rana, S., Hacker, M. R., Modest, A. M., Salahuddin, S., Lim, K.-H., Verlohren, S., Perschel, F. H., & Karumanchi, S. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195065 · Cited by 103 · see citing works

Angiogenic factors and prediction of adverse pregnancy outcomes in suspected preeclampsia: the PROGNOSIS study

Staff, A. C., Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2017) · Pregnancy Hypertension · doi:10.1016/j.preghy.2016.10.007 · Cited by 1 · see citing works

sFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia

Oliveira, L. G., Peraçoli, J. C., Peraçoli, M. T. S., Korkes, H. A., Zampieri, G., Moron, A. F., & Sass, N. (2013) · Pregnancy Hypertension · doi:10.1016/j.preghy.2013.02.003 · Cited by 26 · see citing works

Comment on “Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan”

Fu, Y., & Wang, Y. (2025) · Hypertension Research · doi:10.1038/s41440-025-02377-8

Wnt5a decreases sFlt1 expression in trophoblast cells

Ujita, M., Kondoh, E., Kawasaki, K., Chigusa, Y., Takai, H., Kiyokawa, H., Nishimura, F., Mogami, H., & Konishi, I. (2014) · Placenta · doi:10.1016/j.placenta.2014.08.087